Haddadin Yezan Munther

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 36% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
8 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Haddadin Yezan Munther's trades of Outlook Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
16.85
Quantity 28,801 +5.1%
Value US$1,519,943
Transaction date
Purchase
Price
475.56
Quantity 96,257 +9.1%
Value US$3,032,781
Transaction date
Purchase
Price
1.27
Quantity 3,600 +6.0%
Value US$4,572
Transaction date
Purchase
Price
1.82
Quantity 10,000 +100.0%
Value US$18,200
Transaction date
Purchase
Price
0.72
Quantity 10,000 +inf%
Value US$7,245
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
B Purchase
28,801 +5.1%
16.85
US$1,519,943 		28,801 +5.1% 16.85 US$1,519,943
2026-05-27 2026-05-26
B Purchase
96,257 +9.1%
475.56
US$3,032,781 		96,257 +9.1% 475.56 US$3,032,781
2024-03-29 2024-03-28
B Purchase
90,788 +44.7%
324.63
US$3,434,744 		90,788 +44.7% 324.63 US$3,434,744
2022-10-11 2022-10-07
B Purchase
3,600 +6.0%
1.27
US$4,572 		3,600 +6.0% 1.27 US$4,572
2022-10-11 2022-10-06
B Purchase
29,743 +99.1%
1.29
US$38,368 		29,743 +99.1% 1.29 US$38,368
2021-12-02 2021-12-02
B Purchase
10,000 +50.0%
1.39
US$13,900 		10,000 +50.0% 1.39 US$13,900
2021-04-20 2021-04-19
B Purchase
10,000 +100.0%
1.82
US$18,200 		10,000 +100.0% 1.82 US$18,200
2020-09-22 2020-09-22
B Purchase
10,000 +inf%
0.72
US$7,245 		10,000 +inf% 0.72 US$7,245